66671-1-Ig
antibody from Proteintech Group
Targeting: SRSF1
ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66671-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- ASF/SF2 antibody
- Antibody type
- Monoclonal
- Description
- ASF/SF2 antibody (Cat. #66671-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A6C5
- Vial size
- 20ul, 150ul
Submitted references SRSF1 shapes 3'-end site selection with differential dependence on U1 snRNP.
Long non-coding RNA AFAP1-AS1 promotes alternative splicing of AXIN2 by facilitating SRSFs phase separation to induce drug resistance in lung adenocarcinoma.
Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer.
VP3 protein of Senecavirus A promotes viral IRES-driven translation and attenuates innate immunity by specifically relocalizing hnRNPA2B1.
PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1.
Long-read sequencing and profiling of RNA-binding proteins reveals the pathogenic mechanism of aberrant splicing of an SCN1A poison exon in epilepsy.
Merens HE, Raicu AM, Carroll CL, Kourkoulakos M, Fiszbein A, Churchman LS
bioRxiv : the preprint server for biology 2026 May 5;
bioRxiv : the preprint server for biology 2026 May 5;
Long non-coding RNA AFAP1-AS1 promotes alternative splicing of AXIN2 by facilitating SRSFs phase separation to induce drug resistance in lung adenocarcinoma.
Ouyang J, Zhang Y, Hou X, Xiong F, Shi L, Zhong Y, Yang L, Guo C, Zeng Z, Yan Q, Chen P, Xiong W
Molecular cancer 2025 Nov 20;24(1):294
Molecular cancer 2025 Nov 20;24(1):294
Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer.
Hu Y, Liu W, Qiang D, Huang K, Ruan Q, Chen L
Oncogene 2025 Dec;44(46):4549-4563
Oncogene 2025 Dec;44(46):4549-4563
VP3 protein of Senecavirus A promotes viral IRES-driven translation and attenuates innate immunity by specifically relocalizing hnRNPA2B1.
Li L, Li X, Zhong H, Li M, Wan B, He W, Zhang Y, Du Y, Chen D, Zhang W, Ji P, Jiang D, Han S
Journal of virology 2024 Sep 17;98(9):e0122724
Journal of virology 2024 Sep 17;98(9):e0122724
PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1.
Yan Z, Zhao W, Zhao N, Liu Y, Yang B, Wang L, Liu J, Wang D, Wang J, Jiao X, Cao J, Li J
Acta biochimica et biophysica Sinica 2024 Dec 10;57(8):1338-1349
Acta biochimica et biophysica Sinica 2024 Dec 10;57(8):1338-1349
Long-read sequencing and profiling of RNA-binding proteins reveals the pathogenic mechanism of aberrant splicing of an SCN1A poison exon in epilepsy.
Happ HC, Schneider PN, Hong JH, Goes E, Bandouil M, Biar CG, Ramamurthy A, Reese F, Engel K, Weckhuysen S, Scheffer IE, Mefford HC, Calhoun JD, Carvill GL
bioRxiv : the preprint server for biology 2023 May 4;
bioRxiv : the preprint server for biology 2023 May 4;
No comments: Submit comment
No validations: Submit validation data